Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Hand holding green apple surrounded by micronutrient names | Image credit: mi_viri – stock.adobe.com

Most Patients With Type 2 Diabetes Have Vitamin D Deficiency, Study Suggests

By Hayden E. Klein

January 28th 2025

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient deficient.

Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

By Zachary Villaverde, BS
Roy H. Hinman II, MD

January 17th 2025

Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor

By Kelsey Ernst, PharmD
Amy N. Thompson, PharmD

January 9th 2025

AJMC Q&A with Ian Neeland, MD | Background image credit: ipopba - stock.adobe.com

Overcoming Barriers to Guideline-Directed Cardiometabolic Care

By Hayden E. Klein

January 1st 2025

FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes

By Rose McNulty

December 23rd 2024

More News

March 6th 2023

Making Preventive Drugs Free Doesn’t Change Health Outcomes, Study Finds

Mary Caffrey

The findings of the ACCESS study show the complex challenge of improving medication adherence among the most fragile members of society.

March 5th 2023

HALO Misses End Point, but Optimism Remains for Baxdrostat in Resistant Hypertension

Mary Caffrey

Baxdrostat is a highly selective aldosterone synthase inhibitor; phase 1 studies showed that the therapy caused a sustained, dose-dependent reduction in plasma aldosterone by more than 70% without reducing cortisol.

Deepak L. Bhatt, MD, MPH, Icahn School of Medicine at Mount Sinai

March 2nd 2023

Dr Deepak Bhatt Discusses Results From the ENTRIGUE Trial

Mary Caffrey Maggie L. Shaw

Deepak L. Bhatt, MD, MPH, Icahn School of Medicine at Mount Sinai, has multiple presentations during the upcoming American College of Cardiology Scientific Sessions, including additional phase 2 results from the ENTRIGUE trial for pegozafermin in severe hypertriglyceridemia.

March 1st 2023

Lilly Cuts Some Insulin Prices, Caps Out-of-Pocket Costs

Hayden E. Klein

Eli Lilly announced it will automatically cap out-of-pocket (OOP) costs at $35 at participating retail pharmacies for Americans with commercial insurance using some of its insulin products.

February 28th 2023

Dr Jeremy Wigginton on Preventing, Managing Diabetes in Louisiana

Hayden E. Klein

Jeremy Wigginton, MD, vice president of health quality and innovation at Blue Cross and Blue Shield of Louisiana, explains how the company works with employers to prevent and manage diabetes.

February 23rd 2023

How Rising Insulin Costs Impacted Uninsured Populations

Hayden E. Klein

Researchers looked at trends in insulin usage and expenditure among insured and uninsured populations with diabetes, accounting for how the expansion of Medicaid under the Affordable Care Act may have affected these trends.

February 16th 2023

Dr Daniel Weiner: We Need to Better Prioritize Early Detection, Preventive Care for DKD

Hayden E. Klein Matthew Gavidia

While there are a number of treatments available for diabetic kidney disease (DKD), the biggest limitation is the lack of early detection, said Daniel E. Weiner, MD, MS, board certified nephrologist and lead navigator at Tufts Clinical and Translational Science Institute.

February 6th 2023

Vitamin D Linked to Reduced Diabetes Risk in Adults With Prediabetes

Hayden E. Klein

Adjusted analyses showed vitamin D reduced diabetes risk by 15%, with a 3-year absolute risk reduction of 3.3%.

February 1st 2023

Inconsistent Medication Use Among US Adults With Diabetes

Hayden E. Klein

Research showed that a mean of 19.5%, 17.1%, and 43.3% of adults with diabetes did not maintain continuity in use of medications to lower glucose, blood pressure, or lipid levels, respectively.

February 1st 2023

Role of Insurance Companies in Treating Patients with Diabetes

Treatment strategies for diabetes should include a comprehensive approach involving multidisciplinary care teams.

February 1st 2023

Incentivizing Comprehensive Care Approaches within the Management of Diabetes

Treatment strategies for diabetes should include a comprehensive approach involving multidisciplinary care teams.

January 26th 2023

Adults With Diabetes in High-Deductible Health Plans More Likely to Have Severe Hyperglycemia

Hayden E. Klein

Adults with diabetes who were forced to switch from an employer-sponsored health plan to a high-deductible health plan (HDHP) were 25% more likely to require an emergency department (ED) or hospital visit for hyperglycemia, but not for hypoglycemia, than those who did not switch plans.

January 25th 2023

Identifying Cardiovascular Risk in Patients with Diabetes

Cardiovascular risk can be significantly impacted by the presence of diabetes.

January 25th 2023

Drivers of Cost in the Management of Diabetes

Experts highlight key factors when considering costs associated with diabetes treatment pathways.

January 24th 2023

What We’re Reading: Eli Lilly to Expand Diabetes Drug Plant; Providers Billing for Emails; Gallup Poll on Universal Health Care

AJMC Staff

Eli Lilly will tack on $450 million more to increase capacity in a diabetes drug plant in light of shortages; patients emailing and messaging medical providers online might be charged; 57% of adults in a recent survey think that the federal government should secure health care coverage for all Americans.

paper saying diabetes, covered with pills and medical injections

January 20th 2023

Diabetes Outcomes Better for Patients Enrolled in MA Than FFS Medicare

Hayden E. Klein

A new study highlighted that patients with diabetes enrolled in Medicare Advantage (MA) had better outcomes compared with patients in traditional fee-for-service (FFS) Medicare.

January 18th 2023

A Strategic Approach to Controlling Diabetes

Adequately treating diabetes demands an array of considerations and therapy strategies.

January 18th 2023

A1C Management Strategies

Dr Handelsman drives a conversation surrounding the management of A1C levels.

January 12th 2023

Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care

Hector P. Rodriguez, PhD, MPH Elizabeth L. Ciemins, PhD, MPH, MA Karl Rubio, MIA Cori Rattelman, MS John K. Cuddeback, MD, PhD Jeff T. Mohl, PhD Salma Bibi, MPH Stephen M. Shortell, PhD, MPH, MBA

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.

January 11th 2023

KDIGO 2022 Clinical Practice Guideline: Management Updates for Diabetes, CKD

Hayden E. Klein

Updated guidelines include 13 recommendations and 52 practice points for clinicians treating patients with diabetes and chronic kidney disease (CKD).

January 11th 2023

The Utilization of Combination Therapy in Patients with Diabetes

Key opinion leaders discuss the role of combination therapies in the management of diabetes.

January 11th 2023

Managing Blood Pressure in Patients With Diabetes

Managing hypertension is a critical aspect of diabetes disease management.

collection of health and fitness items, including water bottle, apple, weight, towel, and measuring tape

January 6th 2023

Lifestyle Intervention May Help Reduce T2D Risk in Women With Prior Gestational Diabetes

Hayden E. Klein

A review showed lifestyle intervention was linked to a 24% reduction in type 2 diabetes (T2D) incidence among women with prior gestational diabetes, compared with standard of care.

January 4th 2023

Treatment Strategies for Hyperglycemia

The panel shares insights into the evolution of treatment strategies for patients with diabetes.

January 4th 2023

Insurance Considerations in Diabetes Management

A panel of experts discuss considerations in insurance coverage for the treatment of patients with diabetes.

January 2nd 2023

Contributor: Health Systems Will Need a Tech Transformation to Prepare for CMS Glycemia Measures

Jordan Messler, MD, SFHM, FACP

With data collection beginning on January 1, 2023, most health systems are not prepared for CMS’ new glycemia measures, and those that are will likely be floored by the results, according to the chief medical officer at Glytec.

A graphic with the title and health care icons

December 28th 2022

Top 5 Most Listened to Podcast Episodes of 2022

Justina Petrullo

The top 5 most listened to podcast episodes on AJMC.com in 2022 provided expert commentary on diabetes, lung disease, health policy, Parkinson disease, and more.

December 21st 2022

Top 5 Most-Read Diabetes Content of 2022

Julia Bonavitacola

The top 5 most-read articles about diabetes featured stories on FDA approvals, drug prices, and the effectiveness of vitamin D in diabetes prevention, among others.

December 21st 2022

What We’re Reading: How Spending Bill Affects Medicaid; Widening Disparities in Insulin Use; Confiscated Fentanyl in 2022

AJMC Staff

The new federal spending bill includes changes to Medicaid enrollment, postpartum coverage, and other health programs; new research shows widened disparities among US adults with diabetes using insulin; in 2022, the Drug Enforcement Administration confiscated more than 379 million fentanyl doses.

December 20th 2022

Ethnic Disparities in Glycemic Control Increase in United States

Julia Bonavitacola

A new study has found that Mexican Americans and non-Hispanic Black Americans had low rates of glycemic control compared with non-Hispanic White Americans.

<1 2 3 4 5 6 7 8 9

...

97 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions